2019
Promises of Nanotherapeutics in Obesity
Ash GI, Kim D, Choudhury M. Promises of Nanotherapeutics in Obesity. Trends In Endocrinology And Metabolism 2019, 30: 369-383. PMID: 31126754, PMCID: PMC6716370, DOI: 10.1016/j.tem.2019.04.004.Peer-Reviewed Original ResearchMeSH KeywordsDrug Delivery SystemsEpigenomicsHumansMicroRNAsNanoparticlesNanotechnologyObesityPrecision MedicineConceptsApplication of nanotechnologyNanotechnology methodsDrug deliveryPotential future applicationsFuture applicationsSpecific applicationsMiRNA therapeuticsEarly diagnosticsNanotechnologyTheranosticsApplicationsPersonalized medicineNanotherapeuticsNanotechNutraceuticalsTherapeuticsConsumable productsNovel angleImproved imagingWide rangeDiagnosticsDeliveryCombinatory therapyFuture directionsPromise
2013
The promises and challenges of the use of genomics in the prescription of exercise for hypertension: the 2013 update.
Ash GI, Eicher JD, Pescatello LS. The promises and challenges of the use of genomics in the prescription of exercise for hypertension: the 2013 update. Current Hypertension Reviews 2013, 9: 130-47. PMID: 23971695, DOI: 10.2174/15734021113099990010.Peer-Reviewed Original ResearchMeSH KeywordsBlood PressureExerciseExercise TherapyGenomicsHumansHypertensionPolymorphism, GeneticPrecision MedicineConceptsBP responseCardiovascular disease risk factorsMajor global public health problemGlobal public health problemControl of hypertensionDisease risk factorsEffectiveness of exercisePrescription of exercisePublic health problemExercise prescriptionRisk factorsHypertensionTherapeutic modalitiesAmerican CollegeConsiderable individual variabilityHealth problemsSports medicineAerobic activityModerate intensityNext-generation sequencingAssociation studiesSpecific genetic variantsSignificant proportionMost daysGenetic variants